Bank of America’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-192,300
Closed -$27.7M – 7835
2025
Q3
$27.7M Buy
192,300
+180,000
+1,463% +$22.1M ﹤0.01% 2297
2025
Q2
$1.24M Sell
12,300
-14,700
-54% -$1.12M ﹤0.01% 5147
2025
Q1
$2.06M Buy
+27,000
New +$2.07M ﹤0.01% 4656
2017
Q4
– Sell
-16,200
Closed -$506K – 7126
2017
Q3
$506K Buy
+16,200
New +$309K ﹤0.01% 4945

Other funds holding INSM

Bank of America's INSM Position: Q2 2026 in Review

Bank of America reduced its Insmed (INSM) stake by 32% in Q2 2026, selling an estimated $58M and leaving 1,023,114 shares worth $109M. The position accounts for 0.01% of the portfolio, ranked #1122.

Bank of America first reported a position in INSM in Q2 2013 and has held it in 53 quarters since. The position peaked at $300M in Q4 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Bank of America held 1,023,114 shares of Insmed worth $109M as of Q2 2026.
  • Bank of America sold 479,167 Insmed shares in Q2 2026, an estimated $58M.
  • Insmed made up 0.01% of Bank of America's portfolio in Q2 2026, its #1122 holding.
  • Bank of America first reported a position in Insmed in Q2 2013 and has held it in 53 quarters since.
  • Bank of America's Insmed position peaked at $300M in Q4 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.